{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.answeringMemberConstituency=Newark&uin=45098&writtenParliamentaryQuestionType=Ordinary", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answer.answeringMemberConstituency=Newark&uin=45098&writtenParliamentaryQuestionType=Ordinary", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.answeringMemberConstituency=Newark&uin=45098&_metadata=all&writtenParliamentaryQuestionType=Ordinary", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answer.answeringMemberConstituency=Newark&uin=45098&writtenParliamentaryQuestionType=Ordinary", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.answeringMemberConstituency=Newark&uin=45098&writtenParliamentaryQuestionType=Ordinary", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.answeringMemberConstituency=Newark&uin=45098&writtenParliamentaryQuestionType=Ordinary", "items" : [{"_about" : "http://data.parliament.uk/resources/1503413", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1503413/answer", "answerText" : {"_value" : "
The Department has well established procedures to deal with supply issues with prescription medicines and works with the Medicines and Healthcare products Regulatory Agency, NHS England and industry to prevent shortages and ensure that any risks to patients are minimised should they arise.<\/p>
We are aware of supply issues with some medicines used in the treatment of attention deficit hyperactivity disorder. However, alternative products remain available and communications have been issued to the National Health Service to provide advice.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4320", "label" : {"_value" : "Biography information for Robert Jenrick"} } , "answeringMemberConstituency" : {"_value" : "Newark"} , "answeringMemberPrinted" : {"_value" : "Robert Jenrick"} , "dateOfAnswer" : {"_value" : "2022-09-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-09-27T15:36:57.353Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-09-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Attention Deficit Hyperactivity Disorder: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that patients who require treatment for Attention deficit hyperactivity disorder and similar conditions will not been impacted by potential disruptions to the supply chains for the prescription medications they require.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4658", "label" : {"_value" : "Biography information for Alex Sobel"} } , "tablingMemberConstituency" : {"_value" : "Leeds North West"} , "tablingMemberPrinted" : [{"_value" : "Alex Sobel"} ], "uin" : "45098"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }